酪酸梭菌活菌胶囊治疗抗生素相关性新生儿腹泻的效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (36 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical effect of Clostridum Butyricum Capsule in treating newborns antibiotic associated diarrhea.Methods 100 newborns with antibiotic associated diarrhea in our hospital from January 2015 to June 2016 were selected as study objects and were divided into observation group and control group by using number table, 50 cases in each group.The control group was used Montmorillonite Powder,the observation group was used Clostridum Butyricum Capsule on the basis of control group.Clinical effect,main symptom improvement time and treatment related adverse reactions in two groups were compared.Results In the observation group,33 cases were markedly effective,effective in 15 cases,ineffective in 2 cases,the total effective rate was 96.0%,which were respectively 21,16,13 and 74.0%in control group,the observation group was obvious better than control group and the difference was significant(χ2=6.414, P＜0.05);stool recovery time,vomiting disappearance time and fever disappearance time in observation group were respectively（3.2±1.0）,（2.1±0.4）and（2.2±0.6）d,which were respectively（5.2±1.5）,（4.6±1.1）and（4.5±1.0）d in control group,and the difference was significant(P＜0.05).No drug related adverse reactions occurred in two groups during treatment.Conclusion Clostridum Butyricum Capsule has exactly effect in treating newborns antibiotic associated diarrhea, which can quickly improve the main clinical symptoms of children,with good safety and is worthy to promotion and application in clinical.

Key words： Newborns Antibiotic associated diarrhea Clostridum Butyricum Capsule Montmorillonite Powder

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LONG Zheng
	DU Sheng
	LI Jie-fang

Cite this article:

LONG Zheng,DU Sheng,LI Jie-fang. Effect of Clostridum Butyricum Capsule in treating newborns antibiotic associated diarrhea[J]. 中国当代医药, 2017, 24(5): 131-133.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I5/131

[1]	潘丽.小儿肺炎继发性腹泻应用酪酸梭菌二联活菌散治疗的效果研究[J].中国卫生标准管理，2015，30（12）：88-89.
[2]	张春雨，韩宏梅，王舒悦，等．酪酸梭菌活菌片剂联合思密达及补锌治疗小儿腹泻的临床观察[J].中国实用医药，2015，10（18）：167-168.
[3]	马艳玲，刘文．酪酸梭菌肠球菌三联活菌片联合灌肠疗法治疗小儿腹泻的疗效观察及对机体炎性因子的影响[J].临床和实验医学杂志，2015，20（21）：1711-1713.
[4]	郭水莲.新生儿室诺如病毒性腹泻的护理干预研究[J].现代诊断与治疗，2014，25（23）：5504-5505.
[5]	邱大辉.蒙脱石散联合酪酸梭菌二联活菌散剂治疗小儿腹泻的临床应用[J].中国现代药物应用，2014，7（28）：162-163.
[6]	胡玉莲，徐淑玲，邓彩艳，等.无乳糖奶粉治疗新生儿腹泻的疗效观察[J].中国医药科学，2015，5（8）：55-56.
[7]	梁小连.双歧杆菌活菌胶囊联合思密达治疗轮状病毒性肠炎的疗效观察[J].中国现代医生，2013，51（34）：71-72.
[8]	叶文伟.枯草杆菌、肠球菌二连活菌多维颗粒联合蒙脱石散治疗小儿抗生素相关性腹泻的临床疗效分析[J].实用心脑肺血管病杂志，2013，7（10）：119-120.
[9]	王红榕，李洪福，崔云龙.酪酸梭菌活菌散与蒙脱石散间隔应用治疗小儿病毒性肠炎疗效观察[J].中国儿童保健杂志，2012，2（15）：236-238.
[10]	Al-Faleh K，Anabrees J.Probiotics for prevention of necrotizing enterocolitis in preterm infants[J].Evid Based Child Health，2014，9（3）：584-671.
[11]	Ishikawa H，Akedo I，Otani T，et al.Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectaltumors[J].Int J Cancer，2015，126（5）：762-767.
[12]	肖清华，兰康华.益生菌治疗肠易激综合征40例临床观察[J].中国民族民间医药，2014，23（23）：74.
[13]	李璟，王蔚虹.2013年欧洲益生菌治疗下消化道病症指南解读[J].临床药物治疗杂志，2015，13（1）：1-4.
[14]	施洪刚.益生菌在炎症性肠病临床治疗中的应用探讨[J].中国处方药，2014，12（8）：107.
[15]	彭定华.双歧三联活菌片联合蒙脱石散治疗小儿腹泻的临床效果[J].中国当代医药，2016，23（6）：73-75.